chrisvoncsefalvay/vaers-outcomes huggingface dataset:
As soon as I got the shot, I had sharp pains going down my arm that happen 15 second. I got dizzy, my legs got heavy, and my heart started racing. My blood pressure went up. This all happened within 3 minutes from my shot. I was at cancer center for my shot. So, there was nurses there that monitor me for a while. After about 2 hours and then I got to leave.
Hives/rash starting on inner arms & upper back on Wed, Jan 4th. Spread to lower torso, thighs and severe itching by about 1 a.m Jan 5th. Face flushed but no hives. No fever.
Diarrhea since got the first shot; Skin was white; Everything hurt so bad.; Just touching my skin hurt.; The first one made me extremely sick; I thought I would die; Headache; Temperature was 99.7°F; Chills/was so cold that needed to enter the shower with hot water; Feeling cold; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea since got the first shot), SKIN DISCOLOURATION (Skin was white), PAIN (Everything hurt so bad.), PAIN OF SKIN (Just touching my skin hurt.) and ILLNESS (The first one made me extremely sick) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D45C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea since got the first shot), SKIN DISCOLOURATION (Skin was white), PAIN (Everything hurt so bad.), PAIN OF SKIN (Just touching my skin hurt.), ILLNESS (The first one made me extremely sick), FEELING ABNORMAL (I thought I would die), HEADACHE (Headache), PYREXIA (Temperature was 99.7°F), CHILLS (Chills/was so cold that needed to enter the shower with hot water) and FEELING COLD (Feeling cold). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea since got the first shot) and HEADACHE (Headache) had not resolved and SKIN DISCOLOURATION (Skin was white), PAIN (Everything hurt so bad.), PAIN OF SKIN (Just touching my skin hurt.), ILLNESS (The first one made me extremely sick), FEELING ABNORMAL (I thought I would die), PYREXIA (Temperature was 99.7°F), CHILLS (Chills/was so cold that needed to enter the shower with hot water) and FEELING COLD (Feeling cold) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.7°f (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       About the concomitant medications The patient stated that she is taking some gastrointestinal stuff and something to help digest the food.Been taking medicines and homeopathic   This case was linked to MOD-2021-369270 (Patient Link).
lips, tongue and throat became numb and tingly; lips, tongue and throat became numb and tingly; lips, tongue and throat became numb and tingly; lips, tongue and throat became numb and tingly; developed a cough once the numbness and tingling reached my throat; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK5730), via an unspecified route of administration at the left arm on 18Dec2020 15:30 at a single dose for COVID-19 immunization. Medical history included thyroidectomy for thyroid cancer, anaphylaxis to mangoes and allergic to multiple medications. The patient was not pregnant at the time of vaccination. Concomitant medication included levothyroxine and liothyronine. The patient received the vaccine at 3:30pm, ten minutes later her lips, tongue and throat became numb and tingly. She developed a cough once the numbness and tingling reached my throat. She was given Benadryl at the time, 15 minutes after injection. She was still having numbness and tingling to the back of her tongue currently (8 days after injection). The patient was not hospitalized for the events. The events were reported as non-serious. The vaccine was administered in a hospital. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered on an unspecified date in Dec2020 with sequel.
Administration of expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
Report 2001018603-1 describes dry heaves in a pt who rec'd hepatitis B vaccine recombinant (Engerix-B). Allergies, medical history, and concomitant medications were unspecified. On 7/31/01, the pt rec'd her first L deltoid dose of Engerix-B, ten minutes after receiving Engerix-B, the pt experienced stomach pain, dry heaves and was hot and sweaty. She was treated with ice applied to the injection site. As of 7/31/01, the adverse events had not resolved.
palpitations and inappropriate sinus tachycardia after your 2nd covid 19 vax and again after booster; sinus tachycardia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), for Covid-19 immunization. The following information was reported: PALPITATIONS (non-serious), outcome "unknown", described as "palpitations and inappropriate sinus tachycardia after your 2nd covid 19 vax and again after booster"; SINUS TACHYCARDIA (non-serious), outcome "unknown", described as "sinus tachycardia".  Additional information: It was reported that, the patient (mom) was being evaluated for palpitations and inappropriate sinus tachycardia after her 2nd Covid 19 vax and again after the booster. Stated that, no history of true myopericarditis.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER_INC-202200463172
He had Covid/ him catching or having Covid-19; He had Covid/ him catching or having Covid-19; This is a spontaneous report via Pfizer sponsored program and from a contactable consumer (patient). A 42-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection), via an unspecified route of administration on 26May2021 (Batch/Lot number was not reported) as single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received first dose on 26May2021 and was scheduled to receive second dose on 16Jun2021, however the patient missed the appointment due to catching or having Covid-19. The patient wanted to know if the patient should wait a specific time before the second vaccine and reschedule the appointment. The patient underwent lab tests and procedures which included SARS-CoV-2 test which was positive. The outcome of both events was unknown.  Information on the lot/batch number has been requested.
Patient passed out 5-10 minutes after receiving vaccine. 911 was notified. His wife said he "got up to walk to the car because he overheated and fainted upon standing." He lost consciousness for a second time. The patient laid on a couch in the pharmacy until the ambulance arrived.  His wife noted that he "has a history of heat related syncope and has been very stressed this week."  Vaccine given - 5:45pm, Syncope - 5:50
deep muscle pain & wasting (weakness) which led to shoulder instability & injury which required surgery;
01/05/22 presents to ED for "fall". PMHx of "COPD, HTN, PAD, squamous cell carcinoma, DM"
This spontaneous report as received from a healthcare professional refers to a patient of unknown age and gender. On 22-JAN-2015, the patient was vaccinated with an expired dose of M-M-R II (lot #, dose and route were not reported) expiration date 08-NOV-2014. No adverse effects reported. Additional information has been requested.
Patient developed flushing, fever, dizziness and headache within 30 minutes of receiving Moderna COVID-19 vaccine.  First dose.  Patient reported no previous issues with vaccines and no known issues with any component of the Moderna vaccine.  Patient was taken to a cooler location to lie down.  Improvement was noted within 10 minutes.
extreme flare of psoriasis. prior to booster, it was confined to small patches on calves.  About 10 days after booster, massive patches on arms, legs, chest, neck, scalp and buttocks.
Narrative:  H&P Hospital 11/28 and 11/29/2021 Admitted with Bilateral PE. COVID-19 vaccine #1 - 9/13 COVID-19 vaccine #2 - 10/11. Within 7 days of the second injection, he had a rash on left side of body. Had steroid injection from urgent care but rash did not resolve. Second visit with rash and dyspnea on exertion approx 10-14 days after 2nd COVID-19 dose. Prolonged course of steroids with some improvement in itching but SOB still present and he, again, went to urgen tcare. Treated with another prescription. Today SOB and slightly worse and experienced syncope when was thinking of coming to ER. EMS called - came to hospital. Hx GERD, HTN, PTSD, HLD. \ CXR. EKG RSR, PAC's, Left axis deviation and ST segment depression in leads 1, aVL, V4, V5, V6, D-dimer 11 INR 1 ProoBNP 56 CK CTA PE multiple b/l peripheral PE's. Mild right heart strain. No chest pain. High sensitivity troponin 110 Repeat High sensitivity troponin 505 Admit to inpatient status. PE - given timing, appears to be mRNA vaccine inflammatory  related hypercoagulable state. Lovenox 1 mg/kg Transition to Eliquis 10mg BID x 7 days course Recommended course of treatment 3-6 months. Up to date on age appropriate cancer screenings. No FH of hypercoagulable disorde.r Check Echo. High Troponin - likely related to PE, no CP, consider non-STEMI Trend troponin Trend EKG ASA daily Continue statin Weight based Lovenox Lymphadenopathy vs normal variant for ptt. /L US of axillary lymph nodes to assess for possible Anatomic abnormality. Generalized rash - appears urticarial - itchy folliculitis LLE. No evidence of infection, no petechiae. Multiple courses fo steroids over past several weeks w/o improvement. ?Autoimmune - ANA, CRP, ESR Loratadine 10mg BOD Hydroxy 25mg QID PRN Pepcid 20mg BID Doxycycline 100mg BID x 7 days Complication due to vaccination Unless another diagnosis sdor possible underlying malignancy is found, the ptt is likely experiencing mRNA vaccine hypercoagulable state post vaccination status. BPH w/o outflow obstruction Continue current medical management. HLD - statin Essential HTN - antihypertensive regimen adjust meds as needed. GERD - PPI Chronic depression - anti-depressant Plan - Lovenox AS above
Pt was in the covid clinic and after the shot started with tightness in the throat was given 50mg of po benadryl
A consumer report has been received. The report concerns, Female consumer, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. The patient experienced congestion which started during 2011. The patient recovered from the event of CONGESTION on an unspecified date. The report was considered to be non-serious.
Information has been received from a RN concerning a 12 month old female who on 11Jul05 was vaccinated with a dose of varicella virus vaccine live (lot 648315/0072R). On 21Jul05 The pt broke out with 50 or more lesions. It was reported that most of the pox were maculopapular, but three were described as vesicular. The pt felt warm to the touch but it was unk if a fever was present. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Lower back pain; Feeling unwell; Shingles on stomach and back; Rash; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included tetanus vaccine toxoid; diphtheria vaccine toxoid; pertussis vaccine acellular (TDAP) received 14 days after (as reported) an unknown date in 2021. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Feb2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12Apr2021, the patient started to experience lower back pain and felt unwell. She thought it was a urinary tract infection (UTI). The patient had shingles on her stomach and back and also reported that the rash started 3 days back (12Apr2021). Since the vaccination, the patient had not been tested for COVID-19. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of events and included treatment with steroids and antivirals. The clinical outcome of the events lower back pain, feeling unwell, shingles on stomach and back and rash was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Maculo Papulo vesicular rash on vaccine administration site approximately 6 days post administration.  4/6/07 Received medical records from PCP which reveal patient experienced mild URI symptoms on 3/27/07 day of vax.  Vaccination record included. 5/4/07 Received medical records from hospital which reveal patient experienced erythematous rash w/pain & pruritis on left thigh & gluteus, macular vesicular apulae in appearance.  Admitted 4/3-4/5/07.  Tx w/IV antibiotics for initial cellulitis.  Dermatology & Allergology consults done.   Temp in hospital 102.9 FINAL DX: Herpes zoster left leg.
Nurse gave additional PCV 13 when child doesn't need another one. Pt has received 2 doses after the age of 2 years old. Gave vaccine out of guideline by mistake.
pt recv vax  in 1960's;pt exp a failure to possess immunity to measles;
Swelling of mouth, jaw and throat; Swelling of mouth, jaw and throat; Swelling of mouth, jaw and throat; This spontaneous case was reported by a pharmacist and describes the occurrence of MOUTH SWELLING (Swelling of mouth, jaw and throat), SWELLING FACE (Swelling of mouth, jaw and throat) and PHARYNGEAL SWELLING (Swelling of mouth, jaw and throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOUTH SWELLING (Swelling of mouth, jaw and throat), SWELLING FACE (Swelling of mouth, jaw and throat) and PHARYNGEAL SWELLING (Swelling of mouth, jaw and throat). At the time of the report, MOUTH SWELLING (Swelling of mouth, jaw and throat), SWELLING FACE (Swelling of mouth, jaw and throat) and PHARYNGEAL SWELLING (Swelling of mouth, jaw and throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment/concomitant medications were reported.
Only after vaccine I became allergic to amoxicilin, bug bites, foods, spices, enviromental factors; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient received bnt162b2 (BNT162B2), administration date 17Feb2021 (Lot number: EL9266) at the age of 60 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "ehlers danlos syndrome" (unspecified if ongoing). There were no concomitant medications. The following information was reported: HYPERSENSITIVITY (non-serious) with onset 2021, outcome "unknown", described as "Only after vaccine I became allergic to amoxicilin, bug bites, foods, spices, enviromental factors".  Addition Information: Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  No follow-up attempts are possible. No further information is expected.
Initial report received from a physician on 29 Dec 2009: This patient with an unknown medical history was vaccinated with Novartis H1N1 IM on 21 Dec 2009. On 27 Dec 2009, the patient experienced coughing, chest discomfort, diaphoresis, arthralgia, and myalgia in his lower extremities. These symptoms were dissipated (improved).
almost killed me; Initial information received on 15-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient of unknown age who reported almost killed the patient (feeling abnormal), while being received vaccine influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient was almost killed (feeling abnormal).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
bad reaction; pain/soreness all over body; This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse reaction and general body pain. On an unknown date, the outcome of the adverse reaction and general body pain were not recovered/not resolved.   It was unknown if the reporter considered the adverse reaction and general body pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the Shingrix vaccine and was experienced a bad reaction including severe pain and soreness all over her entire body.  The reporter refused to provide any additional details or demographic information. The reporter did not consent to follow up.
VACCINE WAS ADMINISTERED ON 3/7/23 AFTER EXPIRATION DATE (2/24/23).
Neck pain; Right leg swelling; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills). At the time of the report, NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication reported   No Treatment information reported   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow-up received on 26-APR-2021 contains Non-significant information; Reporter details updated
Shivers, terribly cold, then water diarrhea for 18 - 24 months
Late Sept. had deep pain in arm and shoulder early Oct. saw chiropractor for treatment of pain could not use left arm for over two months. Use still limited due to pain and unintential reflexes. Did not connect pain with vaccine until late December.
Cold sores; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold sores) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Tachycardia. Concomitant products included ALENDRONATE SODIUM (ALENDRONIC) for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced ORAL HERPES (Cold sores). At the time of the report, ORAL HERPES (Cold sores) outcome was unknown. Not Provided          Treatment include Valacyclovir for cold sores.   Reporter did not allow further contact
Diarrhea starting 1/6/2022 that hasn't stopped. Got substantially worse after 2nd dose with blood and mucus. Diagnosed as Ulcerative Colitis.
pt devel inject site reaction consisting of swollen, red arm. felt feverish - temp not taken
Moderna COVID-19 Vaccine EUA,   after waiting 15 minutes after vaccine, I left and stopped at a restaurant for a plate to go home, went home and began eating,  after awhile  i became very nauseated and seemed to not taste my food, but that was intermittent.  about 2-3 hours later i became very ill with hoarse cough, bad headache, low grade temp of 99.6 ...this continue thru the night, not letting me get much sleep, next day, Thursday, my left arm was so very sore i couldnt lift it, but the pain went across the top of my back to top of my right arm...couldn't raise either arm.  Friday continued to feel the same sickness, nauseated, headache, off and on low grade temp and pain  in arms and upper back. I was taking 800mg Ibuprofen 3 times a day and it would ease off headache a little, but nothing  would stop for long.  I was just miserable. had heard the 2nd vaccine could cause such problems, but not the first...therefore, I am a little frightened of getting the 2nd vax. I tried to call the triage nurse at the VA to  ask her about it, but never could get thru to her.  Sent message saturday night to PCP, and was told to go to this website and put in info.